CAPRICOR THERAPEUTICS, INC. Quarterly Operating Lease, Right-of-Use Asset in USD from Q4 2020 to Q3 2024

Taxonomy & unit
us-gaap: USD
Description
Amount of lessee's right to use underlying asset under operating lease.
Summary
Capricor Therapeutics, Inc. quarterly Operating Lease, Right-of-Use Asset history and growth rate from Q4 2020 to Q3 2024.
  • Capricor Therapeutics, Inc. Operating Lease, Right-of-Use Asset for the quarter ending September 30, 2024 was $1.49M, a 32.6% decline year-over-year.
Operating Lease, Right-of-Use Asset, Quarterly (USD)
Operating Lease, Right-of-Use Asset, YoY Quarterly Growth (%)
Period Value YoY Chg Change % Date Report Filed
Q3 2024 $1.49M -$723K -32.6% Sep 30, 2024 10-Q 2024-11-14
Q2 2024 $1.67M -$357K -17.6% Jun 30, 2024 10-Q 2024-08-08
Q1 2024 $1.85M -$344K -15.7% Mar 31, 2024 10-Q 2024-05-14
Q4 2023 $2.05M -$300K -12.8% Dec 31, 2023 10-Q 2024-11-14
Q3 2023 $2.22M -$347K -13.5% Sep 30, 2023 10-Q 2023-11-14
Q2 2023 $2.03M -$516K -20.3% Jun 30, 2023 10-Q 2023-08-08
Q1 2023 $2.19M -$494K -18.4% Mar 31, 2023 10-Q 2023-05-12
Q4 2022 $2.35M -$472K -16.7% Dec 31, 2022 10-K 2024-03-11
Q3 2022 $2.56M Sep 30, 2022 10-Q 2022-11-10
Q2 2022 $2.54M Jun 30, 2022 10-Q 2022-08-12
Q1 2022 $2.68M Mar 31, 2022 10-Q 2022-05-11
Q4 2021 $2.82M +$2.82M Dec 31, 2021 10-K 2023-03-17
Q4 2020 $0 Dec 31, 2020 10-K 2022-03-11
* An asterisk sign (*) next to the value indicates that the value is likely invalid.